News - Page 2

Siv Furholm with PC

After one year with preparations, the EPoS (European Polyp Surveillance Trial) trial has started patient recruitment. The EPoS study will include 30,000 patients over the next three years. Aim of the study is to find better surveillance intervals for patients with colorectal polyps.

The Clinical Effectiveness Research Group recently held a course in Medical Publishing hosted by the University of Bari in Italy. The course was a great success and the participants were satisfied with both the execution and the content of the course.

In the past years we have had a heated debate on the benefits and harms of mammography screening. In this review, the authors discuss the benefits and harms in light of findings from randomized trials, and from more recent observational studies performed in the era of modern diagnostics and treatment.

This review outlines the most current thinking regarding the effectiveness of colonoscopy as a screening tool. It also outlines key concepts to optimize its performance through robust quality assurance programmes and high-quality training. The review is published in GUT.

Guest researcher Michal Kaminski at the Institute of Health and Society received on October 19th an award for outstanding achievements within his field of research in his home country Poland. He is awarded for his work on colorectal cancer and screening.

The NORCCAP- study (NORwegian Colorectal CAncer Prevention) including 100.000 participants shows that flexible sigmoidoscopy screening reduces the risk of colorectal cancer by 20 %. The results are published on August 13th in one of the most prestigious general medical journals; JAMA (Journal of the American Medical Association)

A new Cochrane meta-analysis evaluates flexible sigmoidoscopy and fecal occult blood test (FOBT) screening for colorectal cancer. Both methods reduce colorectal cancer mortality.